Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
2/2019 ceased to operate
LogicBio Therapeutics
LogicBio Therapeutics Overview
LogicBio Therapeutics develops gene therapy vectors for previously incurable genetic and infectious diseases, including hemophilia, HIV/AIDS, and methylmalonic acidemia. The company's proprietary technology is based on the nonpathogenic adeno-associated viral vector. The technology may offer improved efficiency and safety, and it is well suited for the treatment of both children and adults.
LogicBio Therapeutics Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 21, 2018
www.calcalistech.com
LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO
#Public Trading #Investment
Jun 28, 2017
www.fiercebiotech.com
Arix leads $45M series B for gene therapy biotech LogicBio
undefined
Jun 28, 2017
www.globes.co.il
Gene therapy co LogicBio raises $50m
#Investment #Expand
Jan 21, 2016
medcitynews.com
OrbiMed-backed LogicBio raises $4M for hemophilia gene therapy